Page 667 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 46 Eosinophil-Associated Gastrointestinal Disorders 640.e1

MUL ti PL e -CHO i C e QU e S ti ONS

1. Eosinophilic esophagitis: 3. Eosinophilic gastroenteritis:
A. Is the most common entity among the eosinophil A. Is a rare disease with unclear pathogenesis
gastrointestinal disorders (EGIDs) B. Can be diagnosed only after exclusion of infections and
B. During the natural course of the disease, often involves intestinal allergies
stomach and small bowel C. Can involve each segment of the gastrointestinal tract
C. Is mainly triggered and driven by food-antigens D. Swallowed topical steroids are currently considered as
D. Immunoglobulin E (IgE)-based testing plays a crucial role first-line drugs
in the identification of causative foods
4. Hypereosinophilic syndromes:
2. Eosinophilic esophagitis: A. Have an unforeseeable and sometimes even fatal natural
A. Must be treated only when a patient’s quality of life is course
markedly impaired B. Involve mainly the gastrointestinal tract and seldom other
B. Can be treated with drugs, diet, or dilatation organ systems
C. Dilatation is regarded as first-line treatment due to the C. Encompass a group of entities with different immune
rapid symptom resolution pathogeneses
D. Swallowed topical steroids and elimination diet have a D. Require a comprehensive hematological and multisystem
comparable efficiency examination